Shareholders' Equity (Details) - Option [Member] - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Total Options Outstanding | ||
| Beginning balance | 1,661,466 | 243,182 |
| Issued | 1,255,000 | 1,452,880 |
| Cancelled | (247,600) | (34,596) |
| Ending balance | 2,668,866 | 1,661,466 |
| Outstanding, vested and exercisable | 1,242,831 | |
| Weighted Average Remaining Term (Years) | ||
| Outstanding Beginning | 8 years 11 months 4 days | |
| Outstanding Ending | 8 years 1 month 2 days | |
| Outstanding Ending, vested and exercisable | 7 years 8 months 19 days | |
| Weighted Average Exercise Price | ||
| Beginning balance | $ 3.38 | $ 4.88 |
| Issued | 1.44 | 3.19 |
| Cancelled | 3.27 | 5.70 |
| Ending balance | 2.48 | 3.38 |
| Outstanding, vested and exercisable | 2.94 | |
| Weighted Average Fair Value at Issue | ||
| Beginning balance | 2.38 | 4.09 |
| Issued | 1.13 | 2.21 |
| Cancelled | 2.04 | 4.23 |
| Ending balance | $ 1.78 | $ 2.38 |
| Outstanding, vested and exercisable | 2.13 | |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options vested. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|
| X | ||||||||||
- Details
|